|
|
S Levak-Frank, H Radner, A Walsh, R Stollberger, G Knipping, G Hoefler, W Sattler, P H Weinstock, J L Breslow, R Zechner
J Clin Invest. 1995;
96(2):976
doi:10.1172/JCI118145
Abstract |
Full text
| PDF

I
n extrahepatic tissues lipoprotein lipase (LPL) hydrolyzes triglycerides thereby generating FFA for tissue uptake and metabolism. To study the effects of increased FFA uptake in muscle tissue, transgenic mouse lines were generated with a human LPL minigene driven by the promoter of the muscle creatine kinase gene. In these mice human LPL was expressed in skeletal muscle and cardiac muscle, but not in other tissues. In proportion to the level of LPL overexpression, decreased plasma triglyceride levels, elevated FFA uptake by muscle tissue, weight loss, and premature death were observed in three independent transgenic mouse lines. The animals developed a severe myopathy characterized by muscle fiber degeneration, fiber atrophy, glycogen storage, and extensive proliferation of mitochondria and peroxisomes. This degree of proliferation suggests that FFA play an important role in the biogenesis of these organelles. Our experiments indicate that LPL is rate limiting for the supply of muscle tissue with triglyceride-derived FFA. Improper regulation of muscle LPL can lead to major pathological changes and may be important in the pathogenesis of some human myopathies. Muscle-specific LPL transgenic mouse lines will serve as a useful animal model for the investigation of myopathies and the biogenesis of mitochondria and peroxisomes.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(35)
| Title and authors |
Publication |
Year |
Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction
Xue Xue, Song You, Qiang Zhang, Yan Wu, Guozhang Zou, Paul C Wang, Yuliang Zhao, Yan Xu, Lee Jia, XiaoNing Zhang
|
Mol. Pharmaceutics
|
2012 |
Comprehensive Physiology
George A. Bray, David A. York
|
Comprehensive Physiology
|
2011 |
Dietary l-arginine supplementation differentially regulates expression of lipid-metabolic genes in porcine adipose tissue and skeletal muscle
Bie Tan, Yulong Yin, Zhiqiang Liu, Wenjie Tang, Haijun Xu, Xiangfeng Kong, Xinguo Li, Kang Yao, Wanting Gu, Stephen B. Smith, Guoyao Wu
|
The Journal of Nutritional Biochemistry
|
2011 |
Lipoprotein lipase mediated fatty acid delivery and its impact in diabetic cardiomyopathy
Min Suk Kim, Ying Wang, Brian Rodrigues
|
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
|
2011 |
Mechanisms of lipase maturation
Mark H Doolittle, Miklós Péterfy
|
Clinical Lipidology
|
2010 |
Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy
Barbara Gürtl, Dagmar Kratky, Christian Guelly, Lefeng Zhang, Gregor Gorkiewicz, Suman Kumar Das, Kuppusamy Palaniappan Tamilarasan, Gerald Hoefler
|
International Journal of Experimental Pathology
|
2009 |
High-fat diets cause insulin resistance despite an increase in muscle mitochondria
C. R. Hancock, D.-H. Han, M. Chen, S. Terada, T. Yasuda, D. C. Wright, J. O. Holloszy
|
Proceedings of the National Academy of Sciences
|
2008 |
Organelle dynamics and dysfunction: A closer link between peroxisomes and mitochondria
F. Camões, N. A. Bonekamp, H. K. Delille, M. Schrader
|
J Inherit Metab Dis
|
2008 |
Lipoprotein lipase: regulation and role in lipoprotein metabolism
T. Olivecrona, M. Hultin, M. Bergö, G. Olivecrona
|
Proc. Nutr. Soc.
|
2007 |
Impact of Weight-Loss Medications on the Cardiovascular System
Benoit Drolet, Chantale Simard, Paul Poirier
|
American Journal of Cardiovascular Drugs
|
2007 |
|